BRIEF-Simcere Pharmaceutical Enters Exclusive Licensing Agreement With Boehringer Ingelheim
Reuters
Jan 27
BRIEF-Simcere Pharmaceutical Enters Exclusive Licensing Agreement With Boehringer Ingelheim
Jan 27 (Reuters) - Simcere Pharmaceutical Group Ltd 2096.HK:
ENTERS EXCLUSIVE LICENSING AGREEMENT WITH BOEHRINGER INGELHEIM
BOEHRINGER INGELHEIM GRANTED EXCLUSIVE RIGHTS TO SIM0709 OUTSIDE GREATER CHINA
ELIGIBLE FOR EUR42 MILLION UPFRONT AND UP TO EUR1,016 MILLION IN MILESTONES
Further company coverage: 2096.HK
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.